Batch-to-release visibility
Production, in-process control, QA disposition and finished-goods release required one controlled operating flow.
Life sciences engagement
Building a GMP-aware digital operating model that connects batch execution, quality, traceability, systems and investment decisions.
The challenge
The manufacturer needed a practical path from siloed and partly manual operations toward integrated, traceable and data-driven production. The roadmap had to respect pharmaceutical quality controls while remaining technology-neutral and investment-conscious.
Production, in-process control, QA disposition and finished-goods release required one controlled operating flow.
Document control, deviations, CAPA, training and change control needed structured digital workflows and auditability.
The factory planned an ERP but required selection criteria covering lots, expiry, quality holds, traceability and access control.
Equipment, environmental systems, utilities and warehouse devices needed a staged connectivity and data strategy.
DigiLink engagement
The work combined assessment, feasibility and a sequenced transformation program with owners, dependencies, deliverables and success measures.
Interpret current and target maturity across process, technology and organization.
Map batch-to-release, quality controls, system responsibilities and data governance.
Prioritize ERP, eQMS/eDMS, connectivity, automation, intelligence and workforce readiness.
Connect the roadmap to feasibility, roles, validation gates and measurable acceptance criteria.
Verified engagement outcomes
A detailed transformation roadmap aligned to batch control, quality, traceability, data integrity and controlled operations.
Actions were assigned owners, durations, deliverables, success metrics and parallel timing across the transformation horizon.
The operating, technology, workforce and investment assumptions were connected in a structured factory-modernization study.
Related experience
Plan with evidence